comparemela.com

Latest Breaking News On - Fengting yan - Page 1 : comparemela.com

Promising New Treatment for Patients with HR+ HER-

Promising New Treatment for Patients with HR+ HER-
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
American
Geoffreyj-lindeman
Kan-yonemori
Jee-hyun-kim
Fengting-yan
Meng-li
Patricia-lorusso
Timothy-clay
Toru-mokuhara
Li-liu

'Beyond proud': Family, friends unveil memorial to remember couple killed in Gorge shooting

Leaders with the Swedish Cancer Institute installed a new memorial to remember their two nurses who were shot and killed at a music festival over the summer.

California
United-states
Blanca-escamilla
Anita-ruiz
Eddie-escamilla
Anna-handford
John-ruiz
Gorge-amphitheater
Brandy-escamilla
Josilyn-ruiz
Kiro-7-news

'Beyond proud': Family, friends unveil memorial to remember couple killed in Gorge shooting – KIRO 7 News Seattle

'Beyond proud': Family, friends unveil memorial to remember couple killed in Gorge shooting – KIRO 7 News Seattle
kiro7.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kiro7.com Daily Mail and Mail on Sunday newspapers.

Sweden
California
United-states
Swedish
James-kelly
Anna-handford
Anita-ruiz
Blanca-escamilla
Josilyn-ruiz
Fengting-yan
Kevin-boyle
Eddie-escamilla

Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment

Date Time Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment Reston, VA-Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy. Nearly two-thirds of invasive breast cancers are ER-positive, and endocrine therapy is the mainstay of treatment for these tumors because of its favorable toxicity profile and efficacy. Should cancer progress in these patients, however, salvage endocrine therapy with molecularly targeted agents or chemotherapy can help.

Portland
Oregon
United-states
Philadelphia
Pennsylvania
Czech-republic
University-of-pennsylvania
Fred-hutchinson-cancer-research-center
Washington
Maryland
Prague
Praha

vimarsana © 2020. All Rights Reserved.